Spironolactone in patients with heart failure and preserved ejection fraction

被引:4
|
作者
Nunez, J. [1 ]
Nunez, E. [1 ]
Sanchis, J. [1 ]
机构
[1] Univ Valencia, INCLIVA, Hosp Clin Univ, Serv Cardiol, Valencia, Spain
来源
REVISTA CLINICA ESPANOLA | 2016年 / 216卷 / 02期
关键词
HOSPITALIZATIONS;
D O I
10.1016/j.rce.2015.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:111 / 111
页数:1
相关论文
共 50 条
  • [41] Spironolactone did not reduce cardiac outcomes in symptomatic heart failure with preserved ejection fraction
    Kelly, Jacob
    Granger, Christopher B.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (08)
  • [42] Heart failure with preserved ejection fraction
    不详
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01):
  • [43] Heart Failure with Preserved Ejection Fraction
    Meyer, Adam
    Kerrigan, Martin
    [J]. HOSPITAL MEDICINE CLINICS, 2015, 4 (03) : 283 - 296
  • [44] Heart failure with preserved ejection fraction
    Arias, Miguel A.
    Alonso-Fernandez, Alberto
    Garcia-Rio, Francisco
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17): : 1828 - 1829
  • [45] Heart Failure with Preserved Ejection Fraction
    Franssen, C.
    Paulus, W. J.
    [J]. NETHERLANDS JOURNAL OF CRITICAL CARE, 2012, 16 (04): : 125 - 132
  • [46] Heart Failure with Preserved Ejection Fraction
    Gladden, James D.
    Chaanine, Antoine H.
    Redfield, Margaret M.
    [J]. ANNUAL REVIEW OF MEDICINE, VOL 69, 2018, 69 : 65 - 79
  • [47] Heart failure with preserved ejection fraction
    Marzia Rigolli
    Gillian A Whalley
    [J]. Journal of Geriatric Cardiology., 2013, 10 (04) - 376
  • [48] A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction
    Belkin, Mark N.
    Blair, John E.
    Shah, Sanjiv J.
    Alenghat, Francis J.
    [J]. ESC HEART FAILURE, 2021, 8 (05): : 3495 - 3503
  • [49] Heart Failure with Preserved Ejection Fraction
    Dalzell, Jonathan R.
    McDowell, Kirsty M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (09): : 896 - 896
  • [50] Spironolactone reduces the risk of mortality and hospitalization in veterans with heart failure with preserved ejection fraction
    Kurgansky, Katherine E.
    Parker, Rachel
    Djousse, Luc
    Joseph, Jacob
    Gagnon, David
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 564 - 565